levofloxacin has been researched along with eye in 16 studies
| Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (eye) | Trials (eye) | Recent Studies (post-2010) (eye) |
|---|---|---|---|---|---|
| 4,346 | 581 | 2,209 | 41,716 | 724 | 8,737 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, Y; Mochizuki, K; Ohkubo, S; Okamura, Y; Tanahashi, T; Tanaka, M; Torisaki, M; Yamashita, Y | 1 |
| Bandello, F; Ferrari, E; Furlanut, M; Pavan, F; Pea, F; Roman-Pognuz, D | 1 |
| Guo, H; Li, J; Liu, Z; Nie, S; Pan, W | 1 |
| Bai, XQ; Deng, SJ; Li, L; Li, R; Liang, QF; Luo, SY; Sun, XG; Wang, ZQ | 1 |
| Choi, JS; Joo, CK; Kim, KA; Lim, JA; Park, SH | 1 |
| Chen, H; Jiang, HR; Wu, XG; Xin, M; Yang, LN | 1 |
| Chen, H; Jiang, H; Liu, T; Song, Z; Wu, X; Xu, Y; Yang, L; Yue, W | 1 |
| Chen, ZJ; Han, L; Sun, ST; Wang, LY; Yue, J; Zhang, YQ | 1 |
| Allouche, S; Dabboussi, F; Hamze, M; Mallat, H | 1 |
| Colaço, R; Fernandes, AI; Galante, R; Mata, JL; Matos, AP; Moutinho, MG; Paradiso, P; Saramago, B; Serro, AP | 1 |
| Ahad, A; Ali, A; Aqil, M; Aslam, M; Baig, MS; Imam, SS | 1 |
| Lei, L; Li, X; Song, Z; Xiong, T; Yu, J; Yu, X | 1 |
| Bao, Z; Lei, L; Li, X; Lin, D; Liu, H; Shi, H; Wang, Y; Xu, X; Yu, A | 1 |
| Chen, WD; Hsu, WH; Huang, TY; Lai, LJ | 1 |
| Bao, Z; Dai, M; Hu, Y; Jin, B; Lei, L; Li, X; Lin, D; Shi, H; Wang, Y; Yu, A | 1 |
| AlQaraghuli, F; Babiskin, A; Le Merdy, M; Lukacova, V; Tan, ML; Walenga, R; Zhao, L | 1 |
1 trial(s) available for levofloxacin and eye
| Article | Year |
|---|---|
Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Aqueous Humor; Cataract Extraction; Endophthalmitis; Eye; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Time Factors | 2005 |
15 other study(ies) available for levofloxacin and eye
| Article | Year |
|---|---|
[Intraocular penetration of oral levofloxacin in rabbits].
Topics: Administration, Oral; Albinism, Ocular; Animals; Autoradiography; Eye; Levofloxacin; Melanins; Ofloxacin; Rabbits; Tissue Distribution | 1994 |
Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes.
Topics: 1-Octanol; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cornea; Drug Carriers; Enoxacin; Ethylene Glycols; Eye; Fluoroquinolones; Gatifloxacin; In Vitro Techniques; Irritants; Levofloxacin; Ofloxacin; Oxaprozin; Permeability; Propionates; Rabbits; Ribavirin; Water | 2006 |
[Analysis on susceptibility of ocular bacterial pathogens to four kinds of fluoroquinolone].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Eye; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2008 |
The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacteria, Aerobic; Ciprofloxacin; Conjunctiva; Eye; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2009 |
Novel mucoadhesive polysaccharide isolated from Bletilla striata improves the intraocular penetration and efficacy of levofloxacin in the topical treatment of experimental bacterial keratitis.
Topics: Absorption; Administration, Topical; Animals; Anti-Bacterial Agents; Aqueous Humor; Bacterial Load; Biological Availability; Cell Line; Cell Proliferation; Cornea; Disease Models, Animal; Endothelial Cells; Eye; Female; Humans; Keratitis; Levofloxacin; Male; Ofloxacin; Ophthalmic Solutions; Orchidaceae; Plant Extracts; Polysaccharides; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tears; Treatment Outcome | 2010 |
Efficacy of gemifloxacin for the treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Anti-Infective Agents, Local; Colony Count, Microbial; Conjunctival Diseases; Cornea; Eye; Female; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Keratitis; Levofloxacin; Male; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2012 |
[The changes of ocular bacterial isolates and in vitro antimicrobial susceptibility in the past six years].
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Eye; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Retrospective Studies; Staphylococcus epidermidis; Tobramycin | 2012 |
Prevalence of first-step mutants among levofloxacin-susceptible isolates of Streptococcus pneumoniae in north Lebanon.
Topics: Blood; Drug Resistance, Bacterial; Ear; Eye; Fluoroquinolones; Humans; Lebanon; Levofloxacin; Lung; Microbial Sensitivity Tests; Mutation; Nose; Pneumococcal Infections; Prevalence; Streptococcus pneumoniae | 2013 |
About the effect of eye blinking on drug release from pHEMA-based hydrogels: an in vitro study.
Topics: Anti-Bacterial Agents; Blinking; Contact Lenses, Hydrophilic; Drug Delivery Systems; Drug Liberation; Elastic Modulus; Eye; Friction; Hydrogels; Levofloxacin; Models, Biological; Models, Chemical; Permeability; Polyhydroxyethyl Methacrylate; Pseudomonas aeruginosa; Staphylococcus aureus; Tears; Water; Wettability | 2015 |
Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Topics: Animals; Anti-Bacterial Agents; Calorimetry, Differential Scanning; Chickens; Disk Diffusion Antimicrobial Tests; Drug Carriers; Drug Delivery Systems; Drug Liberation; Eye; Levofloxacin; Lipids; Nanoparticles; Ophthalmic Solutions; Particle Size; Permeability; Solubility; Stearic Acids; X-Ray Diffraction | 2016 |
Covalently Cross-Linked Chitosan Hydrogel Sheet for Topical Ophthalmic Delivery of Levofloxacin.
Topics: Chitosan; Eye; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Levofloxacin; Polyethylene Glycols | 2018 |
Thermosensitive glycol chitosan-based hydrogel as a topical ocular drug delivery system for enhanced ocular bioavailability.
Topics: Animals; Biological Availability; Cell Line; Chitosan; Drug Delivery Systems; Drug Liberation; Eye; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Levofloxacin; Ophthalmic Solutions; Rabbits; Temperature | 2019 |
Vibrio cholerae non-O1 - the first reported case of keratitis in a healthy patient.
Topics: Administration, Topical; Amikacin; Anti-Bacterial Agents; Aquatic Organisms; Corneal Ulcer; Eye; Humans; Keratitis; Levofloxacin; Male; Middle Aged; Polymerase Chain Reaction; Seawater; Treatment Outcome; Vibrio cholerae non-O1; Vibrio Infections | 2019 |
Glycol chitosan/oxidized hyaluronic acid hydrogel film for topical ocular delivery of dexamethasone and levofloxacin.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chemical Phenomena; Chitosan; Cornea; Dexamethasone; Drug Carriers; Drug Delivery Systems; Drug Liberation; Eye; Hyaluronic Acid; Hydrogels; Levofloxacin; Mice; Microbial Sensitivity Tests; Molecular Structure; Oxidation-Reduction; RAW 264.7 Cells | 2021 |
Clinical Ocular Exposure Extrapolation for Ophthalmic Solutions Using PBPK Modeling and Simulation.
Topics: Animals; Eye; Humans; Levofloxacin; Models, Biological; Ophthalmic Solutions; Rabbits | 2023 |